Munich, Germany

Gilbert Reisbach


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilbert Reisbach: Innovator in Epstein-Barr Virus Vaccine Development

Introduction

Gilbert Reisbach is a notable inventor based in Munich, Germany, recognized for his significant contributions to medical innovations. With a focus on viral diseases, he has developed a groundbreaking vaccine aimed at combating the Epstein-Barr virus (EBV), which is known for its role in various health complications.

Latest Patents

Gilbert Reisbach holds a patent for an innovative vaccine that comprises a particle containing key components such as Epstein-Barr virus structural polypeptides, lytic polypeptides, and membrane lipids. Importantly, this vaccine is designed to be devoid of EBV DNA. The invention ensures that the B-cell transformation capacity of essential EBV polypeptides is disabled while retaining their immunogenicity, enhancing the vaccine's safety and efficacy. Additionally, it outlines methods for generating the particle and its application in producing CD8+ cells that are specific for EBV antigens.

Career Highlights

Reisbach is affiliated with Helmholtz Zentrum München, an esteemed research institution focused on environmental health and medical solutions. His work there underscores a commitment to addressing complex health issues through innovative research and development. His singular patent showcases his expertise in virology and vaccine development.

Collaborations

Collaboration has been a vital component of Reisbach's career, as he has worked alongside esteemed colleagues such as Romana Ruiss and Wolfgang Hammerschmidt. Together, they contribute to advancing the field of immunotherapy, sharing knowledge and insights that foster innovation.

Conclusion

In conclusion, Gilbert Reisbach’s work in developing an Epstein-Barr virus vaccine represents a significant step forward in medical science. His innovative approach, combined with collaborative efforts at Helmholtz Zentrum München, positions him as a key figure in the pursuit of effective treatments for viral infections. The implications of his research extend beyond his patent, potentially paving the way for effective vaccines and therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…